Oncology & Cancer

Host immune classifier HIC assays may predict treatment response

Using a host immune classifier (HIC) test for patients with non-small cell lung cancer (NSCLC) may provide better predictors of treatment response and improve outcomes, according to research presented today at the International ...

Oncology & Cancer

Cancer risk from obesity differs for men and women

This large study included over 100,000 people and was led by researchers at the University of Bristol and the International Agency for Research on Cancer. They found that a higher BMI (body mass index; a measure of total ...

page 11 from 26